Monoclonals and More Issues and Opportunities With Early Treatment Options in COVID-19
ASPR TRACIE. (2021). Monoclonals and More: Issues and Opportunities With Early Treatment Options in COVID-19.
Speakers share current recommendations for use of mAbs and upcoming therapies and the challenges and opportunities that they may pose in conjunction with mAb and other treatments.
Login to rate, favorite, and comments on the article
You must Login to add a comment
- This item doesn't have any comments